The Combination of ATRA and Eltrombopag as the Treatment of Steroid-resistant/Relapse ITP Based on MSC-C5b-9
Clinical trial NCT05438875 · COMPLETED
Trial details
- NCT number
- NCT05438875
- Sponsor
- Peking University People's Hospital
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-12
- Primary completion
- 2024-11-30
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.